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N-Methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) can be reversed by low-frequency stimulation
(LFS) referred to as depotentiation (DP). We previously found GluN2B upregulated in CA1 neurons from post-status epilepticus
(post-SE) tissue associated with an enhanced LTP. Here, we tested whether LFS-induced DP is also altered in pathological GluN2B
upregulation. Although LTP was enhanced in post-SE tissue, LTP was significantly reversed in this tissue, but not in controls.
We next tested the effect of the GluN2B subunit-specific blocker Ro 25-6981 (1 𝜇M) on LFS-DP. As expected, LFS had no effect
on synaptic strength in the presence of the GluN2B blocker in control tissue. In marked contrast, LFS-DP was also attained in
post-SE tissue indicating that GluN2B was obviously not involved in depotentiation. To test for NMDA receptor-dependence, we
applied the NMDA receptor antagonist D-AP5 (50 𝜇M) prior to LFS and observed that DP was abolished in both control and post-
SE tissue confirming NMDA receptor involvement. These results indicate that control Schaffer collateral-CA1 synapses cannot be
depotentiated after fully established LTP, but LFS was able to reverse LTP significantly in post-SE tissue. However, while LFS-DP
clearly requiredNMDA receptor activation, GluN2B-containingNMDA receptors were not involved in this form of depotentiation.
1. Introduction
Synaptic plasticity is the key mechanism of information
storage in the brain [1].While there is no doubt that activation
of postsynaptic N-methyl-D-aspartate (NMDA) receptors is
pivotal for induction of many forms of synaptic plasticity in
the hippocampus, the subtype-specific role of these receptors
with respect of direction of plasticity is highly debated.
In the hippocampus as well as the cortex, GluN2A was
initially found to be related to long-term potentiation (LTP)
in contrast to GluN2B favoring long-term depression (LTD)
[2–4], but this view has been questioned by subsequent
studies [5–8]. Moreover, GluN2B overexpression or reduced
degradation of GluN2B was in fact associated with enhanced
CA1-LTP [9–11]. In addition, we have recently found an
upregulation of GluN2B subunits in CA1 neurons from post-
status epilepticus (post-SE) rats, leading to enhanced TBS-
induced LTP at Schaffer collateral-CA1 synapses [12].
LTP can be reversed by neuronal activity [13, 14] referred
to as depotentiation (DP), and common protocols for DP
are typical LTD-inducing paradigms such as low-frequency
stimulation (LFS). However, LFS appears to be effective only
during a narrow time window since DP was not obtained
when LFS was applied 30min after LTP induction [15, 16].
Thus, the extent of LTP reversal is inversely related to the
interval between LTP induction and DP [17, 18]. Notably,
LFS appears to activate different pathways when delivered to
potentiated synapses (i.e., mediatingDP) or to naive synapses
(i.e., leading to LTD). While AMPA receptor dephosphory-
lation and internalization are common aspects in both LTD
and DP induction, there are significant differences in (1) the
phosphatase mediating AMPA receptor dephosphorylation
[19–22], (2) the GluA1 serine residue dephosphorylated [23,
24], and (3) the enzymatic cascade involved in AMPA recep-
tor trafficking [25, 26].
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As with LTD, there is also a debate whether or not DP
might be attributed to activation of a specific GluN2 subunit.
The evidence so far rather points to an involvement of
GluN2A [27, 28]. However, DP has not been tested in tissue
with GluN2B overexpression or pathological upregulation,
and, on the other hand, LTDwas not changed under these cir-
cumstances [11, 12]. Since LTPwas enhanced in post-SE tissue
with pathological GluN2B upregulation [12], we hypothe-
sized that DP might by unaltered or—even more likely—
reduced in synapses prone to LTP. Unexpectedly, we found
DP to be significantly enhanced in post-SE tissue, and this
enhancement required NMDA receptor activation but was
preserved after pharmacological GluN2B inhibition.
2. Materials and Methods
2.1. Status Epilepticus In Vivo. The muscarinic agonist pilo-
carpine was used to induce status epilepticus (SE) in male
Wistar rats (30–33 days; Charles River, Sulzfeld, Germany)
as described previously [12, 29]. All procedures were per-
formed according to national and international guidelines
on the ethical use of animals (European Council Directive
86/609/EEC). All efforts were made to minimize animal
suffering and to reduce the number of animals used. In
order to reduce peripheral cholinergic effects, rats were first
givenmethyl-scopolamine nitrate (1mg/kg, i.p.) 30min prior
to pilocarpine treatment. Then, pilocarpine hydrochloride
(340mg/kg, i.p.) or saline (referred to as control animals)
was applied, and the animals were carefully monitored to
observe spontaneous seizures with progression into SE. The
onset of SE was determined when an animal had a stage 4 or 5
seizure [30] that was followed by continuous epileptic motor
activity without showing any reaction to sensory stimuli such
as gently touching against the whiskers. When SE did not
develop within 60min, rats were given a second pilocarpine
dose (170mg/kg, i.p.). In order to terminate SE after 40min,
rats received a 500𝜇L bolus injection of diazepam solution
(Ratiopharm, Ulm, Germany, 5mg/mL, i.p.). Occasionally,
diazepamhad to be reinjected in order to stop seizure activity.
Finally, the rats were fed with 5% glucose solution for 1 day
and kept in separate cages.
2.2. Slice Preparation and Maintenance. Hippocampal slices
were prepared using 2–10-month-old male post-SE and con-
trol rats (i.e., 1–3 months after SE). After deep anesthesia with
diethyl ether, rats were decapitated and the brain was rapidly
removed and submerged into oxygenated ice-cold dissec-
tion solution containing 125mM NaCl, 26mM NaHCO
3
,
3mMKCl, 1.25mMNaH
2
PO
4
, 0.2mMCaCl
2
, 5mMMgCl
2
,
and 13mM D-glucose (95% O
2
, 5% CO
2
; pH 7.4; Osm
306–314mosmol/kg). Horizontal brain slices (400 𝜇m) of
the hippocampus were prepared using a vibratome (Cam-
pden Instruments, Loughborough, UK), and slices were
then transferred into a holding chamber containing arti-
ficial cerebrospinal fluid (ACSF) containing 125mM NaCl,
26mM NaHCO
3
, 3mM KCl, 1.25mM NaH
2
PO
4
, 2.5mM
CaCl
2
, 1.3mM MgCl
2
, and 13mM D-glucose (Osm 306–
314mosmol/kg). Slices were continuously bubbled with 95%
O
2
and 5% CO
2
to maintain the pH at 7.4 and were allowed
to recover at room temperature (20–22∘C) for at least 1 hour
before being transferred into recording chamber.
2.3. Electrophysiological Recording and Induction of Synaptic
Plasticity. Hippocampal slices were transferred into an inter-
face chamber and continuously superfused with oxygenated
ACSF at a flow rate of 2mL/min with a volumetric infusion
pumpMCM-500 (MCMedicine Technique GmbH, Alzenau,
Germany) and the solution temperature was controlled at
32 ± 1∘C by (npi Electronic GmbH, Tamm, Germany). The
experiments started after an equilibration time of at least
30min. Field excitatory postsynaptic potentials (fEPSPs)
were recorded using borosilicate glass pipettes (2-3MΩ,
pulled with PIP5 from HEKA Elektronik, Lambrecht, Ger-
many) filled with ACSF. Stimulating and recording electrodes
were placed into CA1 stratum radiatum. Bipolar stimulation
was performed with platinum wire electrode and applied to
Schaffer collaterals with ISO-STIM01M stimulus isolator (npi
Electronic GmbH, Tamm, Germany). Paired-pulse stimula-
tion (interstimulus interval 40ms) triggered by the Master-8
stimulator (A.M.P.I., Jerusalem, Israel) was used in order to
calculate the paired-pulse ratio (PPR).The Schaffer collateral
pathway was stimulated at a rate of 0.033Hz with the baseline
stimulation strength adjusted to 30–40% of the maximal
fEPSP amplitude.
For LTP induction, a theta-burst stimulation (TBS) pro-
tocol consisting of 10 trains with 5 stimuli at 100Hz (200ms
apart) was used. After full establishment of LTP (i.e., after
60min), a low-frequency stimulation (LFS) paradigm (1Hz,
900 stimuli, 15min) was delivered in order to reverse LTP.
LFS-induced depotentiation (LFS-DP) was assessed as the
fEPSP at 60min following LFS (i.e., after 135min of the total
experiment). For these synaptic plasticity experiments, only
2–4-month-old animals were used. In addition to synaptic
plasticity experiments, we also performed control experi-
ments in order to confirm the effect of Ro 25-6981. To this
end, slices from control and post-SE animals were incubated
with CNQX (10 𝜇M) and gabazine (1 𝜇M) in Mg2+-free
ACSF. Following stimulation of Schaffer collaterals, NMDA
receptor-mediated fEPSPs (NMDA-fEPSPs) were obtained.
Under these conditions, we observed a small but consistent
increase of NMDA-fEPSPs (similar for control and post-SE
tissue: 119 ± 6%, 𝑛 = 6 in control and 119 ± 2%, 𝑛 = 7
in post-SE within 40min). We therefore performed inter-
leaved time-control experiments for normalizing the data
obtained with NMDA receptor antagonists. To study the sen-
sitivity of NMDA-fEPSPs, we added first Ro 25-6981 (1 𝜇M),
and after 15min D-AP5 (50 𝜇M) was added to entirely block
the NMDA-fEPSP. After D-AP5, however, we occasionally
observed small residual components that were regarded
as non-NMDA receptor-dependent potential and therefore
subtracted from all precedent fEPSPs. Hence, data are pre-
sented as the percentage of the D-AP5-sensitive fEPSP.These
control experiments confirming the effect of Ro 25-6981 were
performed in 8–10-month-old animals.
Recording signals were amplified and filtered at 1 kHz
by an EXT-10-2F (npi Electronic GmbH, Tamm, Germany).
Analog datawere digitizedwith aMicro1401 analog-to-digital
converter (Cambridge Electronic Design, Cambridge, UK)
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and stored for offline analysis using Signal 2.16 software
(Cambridge ElectronicDesign, Cambridge, UK).The specific
NMDA receptor antagonist D-2-amino-5-phosphonopen-
tanoate (D-AP5) and theGluN2B-specific blocker Ro 25-6981
[(𝛼R,𝛽S)-a-(4-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-
1-piperidinepropanol maleate] were purchased from Tocris
(Bristol, UK). All other chemicals used for physiological
solutions were purchased from Sigma-Aldrich (Taufkirchen,
Germany).
2.4. Statistical Analysis. All data are expressed asmean values
and the standard error of the mean. Statistical compari-
son was performed using Student’s paired two-tailed 𝑡-test,
ANOVA, or Mann-Whitney 𝑈 test (as indicated) with the
level of significance set to 𝑃 < 0.05. Significant differences
were indicated with asterisks in all figures (∗𝑃 < 0.05, ∗∗𝑃 <
0.01).
3. Results
3.1. Enhanced LFS-Induced DP in Post-SE Tissue. The aim
of this study was to investigate low-frequency stimulation-
induced depotentiation (LFS-DP) at Schaffer collateral-CA1
synapses in control and post-status epilepticus (post-SE) rats.
Since GluN2B was upregulated in post-SE tissue leading
to enhanced LTP at Schaffer collateral-CA1 synapses [12],
we hypothesized that LFS-DP might by unaltered or even
reduced at these synapses. To test this, we first induced robust
long-term potentiation (LTP) using a theta-burst stimulation
(TBS) paradigm in tissue from control and post-SE rats. As
shown in Figure 1(b), TBS induced a long-lasting increase
of the fEPSP slope in controls and even more so in post-SE
tissue. After 60min following TBS, we obtained significantly
enhanced LTP levels in post-SE slices (closed symbols, 161 ±
8% of baseline, 60min after TBS, 𝑛 = 19) as compared
to controls (open symbols, 134 ± 5% of baseline, 𝑛 = 11,
𝑃 < 0.05, Figure 1(c)) confirming our previous results [12].
Then, LFS was applied for 15min, and fEPSPs were followed
up again for another 60min. At the end of this prolonged
recording, we observed that LTP was significantly reversed
only in post-SE tissue (122 ± 9% of baseline, 𝑃 < 0.05 versus
pre-LFS), but not in controls (124 ± 8% of baseline, 𝑃 = 0.301
versus pre-LFS). In addition, the fEPSP slopes at the end of
the experiment (i.e., 60min after LFS) were still significantly
larger than under baseline conditions (see diamonds in Fig-
ure 1(c)). Both TBS and LFS did not change the paired-pulse
ratio (PPR) significantly, indicating the postsynaptic origin of
the observed changes (Figure 1(d)). Hence, while LFS failed to
depotentiate Schaffer collateral-CA1 synapses under control
conditions, it did significantly reverse LTP in post-SE tissue.
3.2. NMDA Receptor Involvement in LFS-DP. In a previous
report, we found that GluN2A was not altered in chronically
epileptic tissue, but GluN2Bwas upregulated in these animals
[12]. We therefore hypothesized that the difference in DP
magnitudemight be attributable to upregulated GluN2B sub-
units rather than to GluN2A which seems to be responsible
for DP in control tissue [27, 28]. To test this, we repeated
our experiments and applied the GluN2B subunit-specific
blocker Ro 25-6981 (1 𝜇M) 15min prior to LFS. As shown
in Figure 2(b), TBS again led to a significantly higher LTP
in post-SE (164 ± 8% of baseline, 𝑛 = 6) as compared to
controls (134 ± 9% of baseline, 𝑛 = 9, 𝑃 < 0.05, Figure 2(c)).
However, as depicted in Figure 2(b), GluN2B inhibition byRo
25-6981 did not block LFS-DP in post-SE tissue. On average,
fEPSP slopes were significantly reduced by LFS to 126 ±
10% of baseline values (𝑛 = 6, 𝑃 < 0.05 versus pre-LFS,
Figure 2(c)) indicating that activation of GluN2B-containing
NMDA receptors was not required for LFS-induced DP. In
control tissue, LFS had no significant effect on the fEPSP
slope (136 ± 15% of baseline, 𝑛 = 9, 𝑃 = 0.892 versus pre-
LFS), consistent with a minor role of GluN2B-containing
NMDA receptors in this tissue [12]. Similar to the results
described above, the PPR was also stable during the course of
the prolonged experiment indicating postsynaptically located
expression of LFS-DP (Figure 2(d)).
Since 1 𝜇M Ro 25-6981 did not affect DP in either group,
we were concerned about the efficiency of this compound
under our conditions. Therefore, we performed control
experiments with isolated NMDA receptor-mediated fEPSPs
and tested the sensitivity of Ro 25-6981 (1 𝜇M). As is shown in
Figure 3(b), NMDA receptor-mediated fEPSPs were sensitive
to Ro 25-6981 and entirely blocked by D-AP5. Moreover,
the residual NMDA-fEPSP following Ro 25-6981 was signifi-
cantly larger in control compared to post-SE tissue (67 ± 7%,
𝑛 = 7 versus 46 ± 6%, 𝑛 = 5; 𝑃 < 0.05, 2-way-ANOVA with
Tukey post hoc test, Figure 3(c)). These data are consistent
with enhanced GluN2B-related function [12] and confirm
that 1 𝜇M Ro 25-6981 was efficient in the present study.
Having found that GluN2B was not involved in LFS-
DP, we wondered whether NMDA receptors are generally
required for depotentiation. To address this question, we
carried out a further set of experiments with the same
protocol but replaced Ro 25-6981 by the nonspecific NMDA
receptor blocker D-AP5 (50 𝜇M, Figure 4(b)). Hence, we
added D-AP5 to the bath solution 15min prior to LFS. Again,
LTP was significantly enhanced in chronically epileptic tissue
(post-SE: 163 ± 3%, 𝑛 = 7; control: 136 ± 6%, 𝑛 = 9; 𝑃 < 0.01,
Figure 4(c)), before LFS was applied. LFS, in turn, had no
significant long-term effect on the fEPSP slope (post-SE: 171±
8%, 𝑛 = 7,𝑃 = 0.399 versus pre-LFS; control: 132± 10%, 𝑛 = 9,
𝑃 = 0.774 versus pre-LFS). These results clearly confirmed
the NMDA receptor-dependent nature of LFS-induced DP.
Figure 4(d) demonstrates stable PPR values following TBS
and LFS, which is similar to all experiments above.
When we compared the three experimental paradigms
(i.e.m native conditions, Ro 25-6981, and D-AP5), we were
concerned about the observed variance in posttetanic poten-
tiation (PTP). On average, the PTP values were 173 ± 8%
in control slices (𝑛 = 28) and 185 ± 9% in post-SE tissue
(𝑛 = 32).This difference in PTP, however, was not statistically
different. Next, we plotted box-whisker graphs for PTP and
LTP, respectively, and found that the distribution of data
obtained from post-SE tissue showed higher skewness and
more extreme values (Figure 5). On the other hand, we could
confirm that TBS-induced LTP was significantly enhanced in
post-SE tissue (collectively 162 ± 5%, 𝑛 = 32, as opposed to
134 ± 4%, 𝑛 = 28, in all control slices, 𝑃 < 0.001, Figure 5).
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Figure 1: LFS-induced depotentiation (DP) in post-SE tissue. (a) Sample traces taken at baseline (timepoint 1 in panel (b)), directly before
low-frequency stimulation (i.e., fully established LTP, timepoint 2 in panel (b)), and at the end of the experiment (i.e., depotentiation, DP,
timepoint 3 in panel (b)). (b) Time course of the experiment showing the relative fEPSP slope (in % baseline). Following 10min baseline,
theta-burst stimulation (indicated by arrow) was applied to induced LTP which was allowed to develop for 60min. Then, LFS was applied
in order to depotentiate synapses again. The effect of LFS-induced DP was assessed after a follow-up of another 60min (i.e., at 135min after
LTP induction). While there was a significant difference in LTP between control (open symbols) and post-SE tissue (closed symbols), LFS
caused DP only in post-SE tissue, but not in controls. (c) Bar graph summarizing the relative fEPSP slopes (in % baseline) for three different
timepoints (baseline, LTP, and DP). Diamonds indicate significant differences against baseline. Asterisks indicate significant differences as
indicated by the brackets. (d) Paired-pulse ratio (PPR) of synaptic transmission following double-pulse stimulation (interstimulus interval
40ms) for control (open bars) and post-SE tissue (closed bars) at three timepoints (baseline, LTP, and DP).
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Figure 2: LFS-induced DP in epileptic tissue is not GluN2B-dependent. (a, b) Time course of the experiment showing the relative fEPSP
slope (in % baseline). The GluN2B blocker Ro 25-6981 was applied as indicated by the bar. While LTP in post-SE tissue (closed symbols) was
significantly enhanced as compared to control (open symbols) at timepoint 2 (60min after TBS), there was no significant difference between
both groups at timepoint 3 (i.e., DP) despite the presence of the GluN2B blocker. Sample traces (panel a) were taken at baseline (timepoint
1), directly before LFS (i.e., LTP, timepoint 2), and at the end of the experiment (i.e., DP, timepoint 3). (c) Bar graph summarizing the relative
fEPSP slopes (in % baseline) for three different timepoints (baseline, LTP, and DP). Note that timepoints 2 and 3 are in the presence of the
GluN2B blocker Ro 25-6981. Diamonds indicate significant differences against baseline. Asterisks indicate significant differences as indicated
by the brackets. (d) Paired-pulse ratio (PPR) of synaptic transmission following double-pulse stimulation (interstimulus interval 40ms) for
control (open bars) and post-SE tissue (closed bars) at three timepoints (baseline, LTP, and DP).
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Figure 3: Ro 25-6981 efficiently reduce NMDA receptor-mediated fEPSPs. (a) Sample traces of NMDA receptor-mediated fEPSPs taken at
baseline (CNQX, timepoint 1 in panel (b)), after application of Ro 25-6981 (1𝜇M, timepoint 2 in panel (b)), and at the end of the experiment
(i.e., after D-AP5, timepoint 3 in panel (b)). Note that, at baseline, slices were already incubated inMg2+-free ACSF containing CNQX (10 𝜇M)
and gabazine (1 𝜇M). (b) Time course of the experiment showing the relative fEPSP slope (in % baseline). Following baseline, Ro 25-6981
(1 𝜇M) was added to the bath and allowed to incubate for 15min. Then, D-AP5 (50𝜇M) was applied in order to block all NMDA receptor-
mediated fEPSP. (c) Bar graph summarizing the relative fEPSP slopes (in % baseline) for three different timepoints (CNQX, Ro, and D-AP5).
Asterisks indicate significant differences as indicated by the brackets.
In conclusion, both TBS-induced LTP and LFS-induced
depotentiation are enhanced in post-SE tissue from chroni-
cally epileptic rats.
4. Discussion
The aim of this study was to explore whether synapses prone
to LTP by GluN2B upregulation can be depotentiated by low-
frequency stimulation (LFS). We hypothesized that GluN2B
upregulation in post-SE tissue causing enhanced LTP [12]
would lead to impaired depotentiation (DP). However, we
unexpectedly found DP to be significantly enhanced in this
tissue. More precisely, DP was only accomplished in post-SE
tissue, but not in controls. In addition, we found that DP in
post-SE tissue did require NMDA receptor activation but was
left intact after pharmacological GluN2B inhibition.
The major finding of our study was that—under control
conditions—LFS failed to depotentiate synapses in a state of
fully established LTP, while DP could be induced in post-
SE tissue. The lack of LFS-induced DP in control synapses
is consistent with previous reports. Thus, it has been shown
that LTP reversal appeared only during a narrow time range
after LTP induction and the extent of depotentiation was
inversely related to the interval between LTP induction and
LFS [15, 16, 31]. However, this may in part be an issue of the
DP protocol, because fully established LTP (i.e., 60min after
induction)was demonstrated to be reversed by high-intensity
paired-pulse LFS [28]. The same study demonstrated that
DP was inhibited by low-molecular Zn2+ (30 nM), a voltage-
independent GluN2A antagonist, pointing to a GluN2A-
dependent mediation, while the GluN2B antagonist Ro 25-
6981 had no effect on LTP reversal [28]. In another report, the
preferential role of GluN2A in DP was further supported by
experiments usingNMDAapplication referred to as chemical
DP [27], but it is also known that DP is an age-dependent
synaptic property [16]. Taking this argument, GluN2B abun-
dance showing a natural decline during development appears
to correlate with the propensity of synapses to express DP.
In this context, it is important to note that our experiments
Neural Plasticity 7
Baseline (1)
Control
Post-SE
LTP (2) DP (3)
10ms
1mV
(a)
50
0
100
150
200
250
−10 0 10 20 30 40 50 60 70 80 90 100 110 120 130 140
Time (min)
LFSf
EP
SP
 sl
op
e (
%
)
D-AP5
1
2 3
3
Control
Post-SE
(b)
∗
∗∗
fE
PS
P 
slo
pe
 (%
)
(8) (7)
20
40
60
80
100
120
140
160
180
200
0
Control
Post-SE
Baseline (1) 
(8) (7)
LTP (2)
(8) (7)
DP (3)
⬨
⬨
⬨
⬨
(c)
PP
R 
(fE
PS
P2
/fE
PS
P1
)
Control
0
30
60
90
120
150
180
(8) (8) (8)
PP
R 
(fE
PS
P2
/fE
PS
P1
)
Post-SE
0
30
60
90
120
150
180
(7) (7) (7)
Baseline (1) LTP (2) DP (3) Baseline (1) LTP (2) DP (3)
(d)
Figure 4: LFS-induced DP in epileptic tissue is NMDA receptor-dependent. (a, b) Time course of the experiment showing the relative fEPSP
slope (in % baseline).The NMDA receptor blocker D-AP5 was applied as indicated by the bar. Now, the fEPSP slope in post-SE tissue (closed
symbols) was significantly larger than in control tissue (open symbols) at timepoint 2 (60min after TBS) but remained significantly enhanced
at timepoint 3 (i.e., DP). Thus, D-AP5 blocked LFS-induced DP in post-SE tissue. Sample traces (panel a) were taken at baseline (timepoint
1), directly before LFS (i.e., LTP, timepoint 2), and at the end of the experiment (i.e., DP, timepoint 3). (c) Bar graph summarizing the relative
fEPSP slopes (in % baseline) for three different timepoints (baseline, LTP, and DP). Note that timepoints 2 and 3 are in the presence of
the NMDA receptor blocker D-AP5. Diamonds indicate significant differences against baseline. Asterisks indicate significant differences as
indicated by the brackets. (d) Paired-pulse ratio (PPR) of synaptic transmission following double-pulse stimulation (interstimulus interval
40ms) for control (open bars) and post-SE tissue (closed bars) at three timepoints (baseline, LTP, and DP).
were performed during the chronic stage of pilocarpine-
induced epilepsy, that is, in 2–4-month-old animals. Consis-
tent with the idea of age-related decline of DP, the phenotypic
regression of epileptic tissue to a developmentally immature
stage with predominantly GluN2B expression (for review,
see [32]) was in fact associated with an enhanced LFS-
induced DP.Thus, our data suggest that adult tissue with—in
this case pathological—GluN2B upregulation expressed DP
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Figure 5: Comparison of posttetanic potentiation (PTP) and LTP in all experiments. (a, b) Box-whisker plots show posttetanic potentiation
(PTP, panel (a)) and long-term potentiation (LTP, panel (b)) of all experiments presented in Figures 1, 2, and 4. Note the higher skewness of
the data obtained from post-SE slices in both calculations. There was one control slice (indicated by an arrow) which showed a posttetanic
depression and consequently LTD rather than PTP and LTP. While PTP was not statistically different between control and post-SE tissues,
enhanced LTP in post-SE slices reached statistical significance (𝑃 < 0.001; Mann-Whitney 𝑈 test).
to a similar degree to immature control tissue. While DP
was definitely NMDAR-dependent, the direct requirement
of GluN2B receptors was not supported by our experiments.
Rather, it appears that downstream signaling mechanisms
may be altered concomitantly withNMDA receptor subunits.
For instance, a recent study indicated that muscarinic acetyl-
choline receptor (mAChR) activation interfered with the
association between GluN2B and the Ras-specific guanine
nucleotide-releasing factor 1 (RasGRF1) and treatment with
the mAChR antagonist scopolamine increased the involve-
ment of GluN2B in LTD induction [6]. While these experi-
ments were unable to discern the mAChR subtype involved,
the M1-mAChR at least was downregulated in post-SE tissue
[33]. Thus, it is conceivable that downregulation of mAChR
in post-SE tissue could contribute to the resurgence of DP in
these synapses. Alternatively, there is some evidence that DP
induction involves adenosine A
1
receptor activation [34, 35].
Although it is difficult tomeasure adenosine in post-SE tissue,
there is one report showing an increased immunoreactivity
for ecto-5-nucleotidase, the adenosine producing enzyme,
in the chronically epileptic hippocampus [36] leaving the
intriguing possibility that enhanced DP in post-SE tissue
could be partly due to increased adenosine levels. Thus,
the enhanced DP in chronically epileptic tissue could be
interpreted as a homeostatic process, but the underlying
mechanisms are downstream of the activation of presumably
GluN2A-containing NMDA receptors.
One potential limitation of the present study is that the
involvement of GluN2B has been determined on the basis
of pharmacological experiments. During the last decade,
a number of pharmacological studies have explored a differ-
ential role for GluN2A and GluN2B in LTP and LTD, respec-
tively, but obtained somewhat contrary results [2–4, 6, 7].
This is partly explained by insufficient selectivity of GluN2A
antagonists and the poor efficacy of GluN2B antagonists at
triheteromeric NMDA receptors [37]. However, 1 𝜇M Ro 25-
6981 is commonly used to block GluN2B-containing NMDA
receptors, and functional overexpression of Ro 25-6981-
sensitive NMDA receptor-mediated currents has been found
at multiple synapses following status epilepticus [12, 38].
To deal with this pharmacological problem, genetic models
have also been used to study the role of GluN2 subunits in
LTP and LTD. While transgenic overexpression of GluN2B
or impaired GluN2B degradation enhanced hippocampal
LTP, LTD was not changed under these circumstances [9–
11]. Importantly, this is also true in the case of pathologi-
cal GluN2B upregulation seen in post-SE tissue [12], thus
questioning the requirement of GluN2B in LTD induction.
In addition, CaM kinase II inhibition decreased surface
GluN2B and reduced LTP, but LTD was intact [8]. On the
other hand, constitutively GluN2B-deficient mice do not
survive into adulthood but showed no LTD as neonates
[39], and conditional CA1-specific GluN2B knockout mice
had impaired LTD [40]. Interestingly, a recent report—using
again the pharmacological approach—focused on extrasy-
naptic GluN2B receptors and suggested that GluN2A activa-
tion was required for LTD, but extrasynaptic GluN2B deter-
mined the magnitude of LTD [41]. In summary, the direction
and magnitude of synaptic plasticity seem to depend on the
relative composition and postsynaptic localization of NMDA
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receptors, rather than on the mere presence or absence of
an individual NMDAR subtype. Within this context, it is
important to note that similarly altered NMDAR subtype
expression levels were detected in both the pilocarpine
epilepsy model [12, 29, 42] and specimens from human
temporal lobe epilepsy patients (e.g., [43]). Since GluN2B
upregulation in post-SE animals can be viewed as an acquired
channelopathy, this tissue offers the opportunity to study
NMDAR function without the need for subtype-selective
blockers. Albeit our datawere obtainedwith pharmacological
tools with limitations discussed above, we have previously
found that the sum of both the GluN2B-blocker-sensitive
EPSP component and the GluN2A-blocker-sensitive EPSP
component was equal to the D-AP5-sensitive EPSP suggest-
ing that both EPSP components were quite disjunctive [12].
Hence, while this does certainly not exclude a low efficiency
at heteromeric channels, it indicates that the error made with
pharmacological tools was at least not substantial.
Unraveling the disturbed downstream mechanisms of
NMDAR activation under pathological conditions will help
understand both cognitive deficits in epilepsy and epilep-
togenesis. When comparing depotentiation and LTD, it is
well known that both forms of dampening synaptic strength
involve different signaling mechanisms. A number of dif-
ferences have been identified so far, such as the serine
residue of GluA1 receptors dephosphorylated after LFS [23,
24] and the signaling cascade involved in AMPA receptor
trafficking [26, 27]. In addition, many enzymes involved in
LTD do not appear to play a major role in DP like protein
phosphatase 2A [20] and phosphoinositide 3-kinase 𝛾 [21]
as well as the Janus kinase/signal transducer and activator of
transcription [22]. In contrast, calcineurin A𝛼 mutant mice
had normal LTD but impaired DP [19]. In conclusion, our
study adds a further piece of evidence to this literature that
LTDandDPare distinct synaptic processes since pathological
GluN2B overexpression in post-SE tissue promotes DP but
leaves LTD unaltered. The pathophysiological consequences
of such enhanced DP in post-SE tissue, however, are less
clear. Obviously, synapses are less capable of residing in
a potentiated state, but whether or not this may perturb
memory performance in live animals may not be answered
by our study. Nonetheless, we believe that the enhanced DP
contributes to an altered homeostasis of synaptic mainte-
nance under pathological conditions potentially giving rise
to unstable memory formation and retrieval.
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